Skip to content

Clinical trials

Phase 1 Intellectual Disability trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Intellectual Disability Phase: Phase 1 Country / region: United States Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20161
20232
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Enrolling by invitation1
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Stanford University2
National Human Genome Research Institute (NHGRI)1
University Hospitals Cleveland Medical Center1
University of California, Davis1
Vanderbilt University Medical Center1
Virginia Commonwealth University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Intellectual Disability7
Developmental Disabilities2
Down Syndrome2
Fragile X Syndrome2
Alzheimer Disease1
Attention Deficit Disorder with Hyperactivity1
Autism Spectrum Disorder1
Catatonia1
Chromosome Deletion1
Deafness1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.